Delivery Order SPE2DB22D3501-SPE2DB24FUL27
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a $7,797.84 firm fixed-price delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of IBRANCE 75 MG CAPSULE 21S pharmaceutical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities to...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,248,339 units of IBRANCE 100 MG CAPSULE 21S. The $14,977.62 contract has a performance period through January 29, 2024. Amerisourcebergen Drug Corp, a for-profit organization, has previously supplied pharmaceuticals, medical supplies, and distribution services to DLA under multiple awards. This latest...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide IBRANCE 125 MG CAPSULE 21S pharmaceutical products. The delivery order has a potential value of $7,792.08 and a completion date of March 13, 2024. Amerisourcebergen Drug Corp serves as the prime contractor on this award, and the contract does not have a set-aside designation. The company also holds an...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $14,969.50 contract is for the delivery of IBRANCE 125 MG CAPSULE 21S pharmaceutical product to support military treatment programs and facilities. Amerisourcebergen Drug Corp, a leading global pharmaceutical sourcing and distribution company, has an extensive history of providing pharmaceutical and...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of IBRANCE 100 MG CAPSULE 21S pharmaceutical products to the DLA, with a completion date of February 23, 2024 and a potential value of $15,592.62. The award does not have a set-aside designation....
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $7,792.08 firm fixed-price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical to provide IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through December 2025. The IDC serves as the primary vehicle for...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the supply of IBRANCE 100 MG CAPSULE 21S. The contract has a ceiling value of $7,796.30 and a period of performance through April 5, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical for the provision of a comprehensive range of pharmaceutical...
- This is a $16,247.92 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of IBRANCE 75 MG CAPSULE 21S, with a period of performance ending on June 12, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,792.08 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of IBRANCE 125 MG CAPSULE 21S, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract...
- The U.S. Defense Logistics Agency (DLA) awarded a $7,792.08 firm fixed-price delivery order contract to AmerisourceBergen Drug Corporation for the supply of IBRANCE 125 MG CAPSULE 21S. This contract has an ultimate completion date of September 17, 2024 and was awarded on August 26, 2024. AmerisourceBergen, a major pharmaceutical distributor, holds several multi-million dollar Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range of medical...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUL27Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $7,797.84 to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. The contract is for the provision of IBRANCE 75 MG CAPSULE 21S pharmaceutical products and has a completion date of February 27, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this award, which does not have a set-aside designation. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 2/5/24 |